Enanta Pharmaceuticals, Inc.

ENTA·NasdaqGS·Healthcare
Compare
10.65+0.28 (+2.70%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close10.37
Open10.62
Day range10.2610.85
52-week range10.0617.15
Off day high−1.84%
Off 52-week high−37.90%
Volume251.49K
Avg. volume (3M)252.25K
Market cap310.19M
EPS (TTM)-2.42
Forward P/E-4.49
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.76
Shares outstanding29.13M
Short interest9.31% of float
Earnings dateNov 16, 2026 (est.)
Analyst target21.83
Profit margin−96.89%

Against its peers

Compare in full ›
ENTA ASMB AVIR EDSA IVVD TRDA
Market cap 310.19M 404.57M 357.71M 29.32M 186.76M 197.02M
P/E (TTM) — 19.1 — — — —
Forward P/E -4.5 -7.7 -3.0 — -1.2 -1.6
Price/book 3.1 1.3 1.8 52.9 1.0 0.8
Dividend yield — — — — — —
1-year change −1.39% −36.33% +37.23% +27.65% −58.83% −31.99%
Today +2.70% −0.25% +6.95% −4.82% +8.96% +7.20%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ENTA news ›

From the 4Search news index, newest first.

In the news

4mentions in 30 days
4with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance